Jan Garfinkle
Investing Profile
Arboretum Ventures thesis
All Current Investments Life Science Tools/Diagnostics Medical Devices Pharma Adjacencies Tech-Enabled Care Delivery Exits Life Science Tools/Diagnostics Medical Devices Pharma Adjacencies Tech-Enabled Care Delivery Accuri Cytometers Acquired by Becton, Dickinson and Company, March 2011 Accuri Cytometers BioIQ Acquired by LetsGetChecked, May 2022 BioIQ CardioMEMS Acquired by St. Jude Medical, June 2014 CardioMEMS Dropworks Acquired by Bio-Rad Laboratories, October 2021 Dropworks Esperion Therapeutics Completed Initial Public Offering on June 26, 2013. Esperion Therapeutics EQRx Completed a SPA
Sector and stage focus
- Series B: Medical Devices, Health IT
- Series A: Medical Devices, Health IT
- general: Diverse Investors, Female Investors, Midwest
Recent investments by Jan Garfinkle
Jan Garfinkle has 4 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| NxThera | Series B | Oct 2011 | $22M |
| CardioMEMS | Series F | Oct 2009 | $22M |
| Uptake Medical | Series C | Mar 2012 | $40M |
| BAROnova | Series C | Feb 2013 | $27M |
Frequent co-investors
Jan Garfinkle has co-invested with: Kevin Lalande, Eric Kim.
Is Jan Garfinkle a fit for your round?
Upload your pitch deck and see whether Jan Garfinkle appears in your top 20 matches.
Find investors for your deck